Taofeek Owonikoko

Advancing Oncologic Research Communities in Health Equity (ARCH) K12 Program

National Cancer Institute · K12

Contact PI · $865.2K · University of Maryland Baltimore

Targeting Polo-Like Kinase 1 (PLK1) for Treatment of Small Cell Lung Cancer

National Cancer Institute · R01

Contact PI · $2.5M · University of Maryland Baltimore

University of Maryland Greenebaum Cancer Centersupport Grant

National Cancer Institute · P30

Contact PI · $10.4M · University of Maryland Baltimore

The Johns Hopkins Translational Science Team and Consortium for ETCTN Studies

National Cancer Institute · UM1

PI · $224.8K · Johns Hopkins University

Adaptive SBRT Plus Chemoimmunotherapy for ES-SCLC

Principal investigator · Suspended · Phase 1

University of Maryland, Baltimore

GD2-SADA:177Lu-DOTA Complex in Patients With Solid Tumors Known to Express GD2

Principal investigator · Terminated · Phase 1

Y-mAbs Therapeutics

Study of PLK1 Inhibitor, Onvansertib, in Relapsed Small Cell Lung Cancer

Principal investigator · Recruiting · Phase 2

University of Maryland, Baltimore

Lenvatinib and Iodine Therapy in Treating Patients With Radioactive Iodine-Sensitive Differentiated Thyroid Cancer

Principal investigator · Terminated · Phase 2

Emory University